Seven Fleet Capital Management LP

Source: SEC Form 13F · as of Mar 2026

Seven Fleet Capital Management LP holds 92 biotech & pharma companies tracked by BioSniper, totaling $167.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

92

Total value held

$167.9M

CompanySharesValue
TNGXTango Therapeutics, Inc.502,012$10.5M
RVMDREVOLUTION MEDICINES, INC.80,792$7.9M
TYRATyra Biosciences, Inc.195,685$7.5M
LQDALiquidia Corp187,876$7.1M
AGIOAGIOS PHARMACEUTICALS, INC.209,547$7.1M
IPSCCentury Therapeutics, Inc.2,947,826$6.7M
ELVNEnliven Therapeutics, Inc.164,030$6.4M
PCVXVaxcyte, Inc.108,450$6.3M
COGTCogent Biosciences, Inc.149,399$5.8M
CGONCG Oncology, Inc.75,758$5.1M
PHVSPharvaris N.V.172,731$4.9M
ABVXAbivax SA43,052$4.8M
DNTHDianthus Therapeutics, Inc. /DE/54,258$4.6M
CYTKCYTOKINETICS INC61,269$4.0M
SLNOSOLENO THERAPEUTICS INC115,770$3.9M
ERASErasca, Inc.222,468$3.6M
ROIVRoivant Sciences Ltd.128,168$3.6M
AVTXAvalo Therapeutics, Inc.213,819$3.2M
IDYAIDEAYA Biosciences, Inc.86,283$2.9M
TSHATaysha Gene Therapies, Inc.625,708$2.8M
CMPXCompass Therapeutics, Inc.516,972$2.7M
DMRADamora Therapeutics, Inc.101,248$2.6M
KALVKalVista Pharmaceuticals, Inc.128,487$2.6M
RLAYRelay Therapeutics, Inc.257,738$2.6M
AXSMAxsome Therapeutics, Inc.14,055$2.4M
DFTXDefinium Therapeutics Inc.99,887$1.9M
MLYSMineralys Therapeutics, Inc.69,571$1.9M
MDGLMADRIGAL PHARMACEUTICALS, INC.3,393$1.8M
CTMXCytomX Therapeutics, Inc.371,398$1.7M
SVRASavara Inc295,688$1.6M
CATXPerspective Therapeutics, Inc.379,082$1.6M
ASMBASSEMBLY BIOSCIENCES, INC.56,147$1.6M
NERVMinerva Neurosciences, Inc.248,476$1.5M
ZLABZai Lab Ltd77,858$1.5M
TARSTarsus Pharmaceuticals, Inc.19,800$1.4M
CRVSCorvus Pharmaceuticals, Inc.82,890$1.2M
AVBPArriVent BioPharma, Inc.50,252$1.2M
LRMRLarimar Therapeutics, Inc.256,585$1.2M
KRYSKrystal Biotech, Inc.4,316$1.1M
IVAInventiva S.A.200,141$1.1M
SYRESpyre Therapeutics, Inc.19,690$993K
BCRXBIOCRYST PHARMACEUTICALS INC102,493$976K
XNCRXencor Inc80,000$965K
CLDXCelldex Therapeutics, Inc.29,300$929K
REPLReplimune Group, Inc.120,400$921K
MAZEMaze Therapeutics, Inc.30,707$917K
CLYMClimb Bio, Inc.130,654$895K
CMPSCOMPASS Pathways plc158,021$874K
ALKSAlkermes plc.24,170$855K
SLNSilence Therapeutics Plc156,759$826K
CRBPCorbus Pharmaceuticals Holdings, Inc.85,687$805K
ANTXAN2 Therapeutics, Inc.199,701$683K
DNLIDenali Therapeutics Inc.35,286$677K
UTHRUNITED THERAPEUTICS Corp1,128$669K
LLYELI LILLY & Co720$662K
VSTMVerastem, Inc.123,400$654K
GERNGERON CORP424,180$632K
IRDOpus Genetics, Inc.134,242$611K
IKTInhibikase Therapeutics, Inc.325,600$547K
CNTXContext Therapeutics Inc.190,785$500K
DRUGBRIGHT MINDS BIOSCIENCES INC.6,395$467K
VYGRVoyager Therapeutics, Inc.115,203$445K
GPCRStructure Therapeutics Inc.9,000$434K
PTGXProtagonist Therapeutics, Inc4,000$422K
PRTAPROTHENA CORP PUBLIC LTD CO43,300$421K
NTLAIntellia Therapeutics, Inc.31,500$404K
MISTMilestone Pharmaceuticals Inc.333,333$397K
SABSSAB BIOTHERAPEUTICS, INC.100,000$383K
PALIPALISADE BIO, INC.213,100$373K
GLUEMonte Rosa Therapeutics, Inc.22,530$371K
EWTXEdgewise Therapeutics, Inc.11,701$369K
UNCYUnicycive Therapeutics, Inc.55,700$367K
TRVITrevi Therapeutics, Inc.27,149$324K
EOLSEvolus, Inc.78,057$321K
NKTRNEKTAR THERAPEUTICS4,300$309K
FULCFulcrum Therapeutics, Inc.38,100$292K
SEPNSepterna, Inc.11,445$275K
OCULOCULAR THERAPEUTIX, INC31,296$265K
ZNTLZentalis Pharmaceuticals, Inc.110,000$257K
AMLXAmylyx Pharmaceuticals, Inc.16,671$232K
NUVLNuvalent, Inc.2,072$212K
BEAMBeam Therapeutics Inc.8,804$210K
IRONDisc Medicine, Inc.3,231$207K
WHWKWhitehawk Therapeutics, Inc.54,296$187K
INBXInhibrx Biosciences, Inc.2,482$167K
APGEApogee Therapeutics, Inc.1,969$166K
CCCCC4 Therapeutics, Inc.57,076$150K
PMNProMIS Neurosciences Inc.10,600$135K
PEPGPepGen Inc.59,500$105K
PMVPPMV Pharmaceuticals, Inc.63,498$79K
MGNXMACROGENICS INC13,387$39K
CGEMCullinan Therapeutics, Inc.1,844$26K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Seven Fleet Capital Management LP — Biotech 13F Holdings & Portfolio | BioSniper